Innovation in Ireland →
CEO of Zero Locus
Co-Founder, VP of Technology, Entropic Communications
Founder, Gilt Groupe
Co-Founder and CEO, DNAnexus
Former CEO, Calistoga Pharmaceuticals
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Founder and CEO of Brooks Bell Inc.
Head of global research and development at Life Technologies
May 6, 2015 ·
May 21, 2015 ·
June 1, 2015 ·
Vertex is developing telaprevir for hepatitis C infections.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2015, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.